Angiogenic and Inflammatory Markers of Cardiopulmonary Changes in Children and Adolescents with Sickle Cell Disease
Open Access
- 23 November 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 4 (11) , e7956
Abstract
Pulmonary hypertension and left ventricular diastolic dysfunction are complications of sickle cell disease. Pulmonary hypertension is associated with hemolysis and hypoxia, but other unidentified factors are likely involved in pathogenesis as well. Plasma concentrations of three angiogenic markers (fibroblast growth factor, platelet derived growth factor–BB [PDGF-BB], vascular endothelial growth factor [VEGF]) and seven inflammatory markers implicated in pulmonary hypertension in other settings were determined by Bio-Plex suspension array in 237 children and adolescents with sickle cell disease at steady state and 43 controls. Tricuspid regurgitation velocity (which reflects systolic pulmonary artery pressure), mitral valve E/Edti ratio (which reflects left ventricular diastolic dysfunction), and a hemolytic component derived from four markers of hemolysis and hemoglobin oxygen saturation were also determined. Plasma concentrations of interleukin-8, interleukin-10 and VEGF were elevated in the patients with sickle cell disease compared to controls (P≤0.003). By logistic regression, greater values for PDGF-BB (P = 0.009), interleukin-6 (P = 0.019) and the hemolytic component (P = 0.026) were independently associated with increased odds of elevated tricuspid regurgitation velocity while higher VEGF concentrations were associated with decreased odds (P = 0.005) among the patients with sickle cell disease. These findings, which are consistent with reports that PDGF-BB stimulates and VEGF inhibits vascular smooth muscle cell proliferation, did not apply to E/Etdi. Circulating concentrations of angiogenic and pro-Inflammatory markers are altered in sickle cell disease children and adolescents with elevated tricuspid regurgitation velocity, a subgroup that may be at risk for developing worsening pulmonary hypertension. Further studies to understand the molecular changes in these children are indicated.Keywords
This publication has 61 references indexed in Scilit:
- Levels of soluble endothelium‐derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortalityBritish Journal of Haematology, 2005
- Sildenafil therapy in patients with sickle cell disease and pulmonary hypertensionBritish Journal of Haematology, 2005
- Dysregulated Arginine Metabolism, Hemolysis-Associated Pulmonary Hypertension, and Mortality in Sickle Cell DiseaseJAMA, 2005
- Proinflammatory Cytokines and the Hypermetabolism of Children with Sickle Cell DiseaseExperimental Biology and Medicine, 2005
- Cytokine-Induced Modulation of Cardiac FunctionCirculation Research, 2004
- Regulation of endothelium-derived nitric oxide production by the protein kinase AktNature, 1999
- Acute phase proteins and interleukins in steady state sickle cell diseaseEuropean Journal of Haematology, 1998
- Doppler Tissue Imaging: A Noninvasive Technique for Evaluation of Left Ventricular Relaxation and Estimation of Filling PressuresJACC, 1997
- Type 2 cytokine serum levels in healthy sickle cell disease patients.1997
- Increased Interleukin-1 and Interleukin-6 Serum Concentrations in Severe Primary Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 1995